Short answer

Acadia Healthcare Company Inc (ACHC) filed its Q3 2019 10-Q quarterly report on Nov 6, 2019 for the quarter ended Sep 30, 2019.

Acadia Healthcare Company Inc Q3 2019 10-Q analysis

AI summary of MD&A and risk factor updates

Revenue $777.3M, up 2.1% YoY from $760.9M, with U.S. Facilities contributing $509.4M
Net margin 5.5% vs 6.1% YoY, while income-before-tax margin fell to 6.4% from 7.3%
Best performer U.S. same-facility revenue, up 4.9%; weakest U.K. patient days, down 1.1%
Operating cash flow $213.5M vs $288.7M; capital expenditures $202.7M, including $141.1M expansion spending
Near-term headwinds: U.K. census and labor costs, U.S. operational issues, GBP exchange-rate decline; approximately 650 beds expected in 2019

No material changes to 10-K risk factors disclosed this quarter
Regulatory investigations: April 2019 subpoenas added six facilities over medical necessity, admission eligibility, discharge, length of stay and patient care
Legal exposure: securities class action consolidated April 1, 2019, covering purchases from April 30, 2014 through November 15, 2018
Operational risk: U.S. EBITDA margin declined 140 basis points from temporary facility operational issues
Financial risk: $3.7 billion contractual debt obligations, including $1.5 billion due within 1–3 years

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Compare quarters, check guidance or see what insiders and funds did around the report.